Antipsychotic medication and length of stay at a psychiatric maximum-security unit in Norway (1987-2000)

Nordic Journal of Psychiatry
Sabine Renkel, Kirsten Rasmussen

Abstract

The aim of this study was to evaluate psychopharmacological treatment and the length of stay (LOS) of patients with schizophrenia in a maximum-security psychiatric unit. Data were collected from the hospital files of 82 consecutively admitted patients with schizophrenia who were both admitted and discharged between the years 1987 and 2000. Psychotropic medication and LOS at the time of discharge were registered. Ninety-five per cent of the patients received antipsychotic medication. Zuclopenthixol was the most frequent medication, given to 43% of the patients. Antipsychotic polypharmacy was found in 20% of the cases. Twenty-seven per cent of the patients were medicated with doses above the recommended therapeutic dose range. During the study period, there was no change in the administration and number of psychotropics, but there was an increase in the dosage of antipsychotics. However, LOS was unchanged during the same time. This supports other findings, which suggest that there is no clinical benefit of higher antipsychotic dosage. It is suggested that an optimized medication practice could yield beneficiary effects, not only for schizophrenic symptoms, but also for violence in schizophrenic patients.

References

Oct 1, 1996·Clinical and Experimental Pharmacology & Physiology·M Eichelbaum, B Evert
Jan 1, 1996·International Journal of Law and Psychiatry·K Rasmussen, S Levander
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M ButwellP Taylor
Feb 24, 2001·Medicine, Science, and the Law·C S BrownM Donovan
Apr 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Elizabeth WalshRobin Murray
Nov 2, 2002·The American Journal of Psychiatry·Franca CentorrinoRoss J Baldessarini
Sep 27, 2003·The American Journal of Drug and Alcohol Abuse·Geraldine Scheller-GilkeyAndrew H Miller
Nov 18, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Ulrich M ZangerMichel Eichelbaum
Apr 2, 2004·The American Journal of Psychiatry·Franca CentorrinoRoss J Baldessarini

❮ Previous
Next ❯

Citations

Apr 27, 2012·The Australian and New Zealand Journal of Psychiatry·Elise V GriffithsM Joy Spark
Sep 5, 2017·International Journal of Clinical Practice·Pavel MohrTomáš Melicher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here